-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Akero Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2022 to Q2 2024.
- Akero Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2024 was $1.23M, a 43.6% increase year-over-year.
- Akero Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2024 was $4.01M.
- Akero Therapeutics, Inc. annual Interest Expense for 2023 was $3.1M, a 319% increase from 2022.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)